Mumbai based pharma company Lupin says any kind of price control will be a deterrent for the industry and 30 percent of its portfolio will be impacted if government implements price control measures.
CNBC-TV18's Archana Shukla reports that the GoM will meet on Wednesday to resolve deadlock on pharma pricing policy caused by the submission of suggestions by the finance ministry.